NCT04837482 A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age Status COMPLETED Phase PHASE3
NCT04806503 A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia. Status TERMINATED Phase PHASE2
NCT04774237 Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia Status COMPLETED Phase PHASE2
NCT04755231 Post-Market Clinical Study of the PanOptix Intraocular Lens (IOL) in a Chinese Population Status COMPLETED Phase NA
NCT04739085 Level of Agreement Between Clinical Defocus Curves and the Web-based Democritus Digital Acuity Reading Test wDDART Status UNKNOWN Phase N/A
NCT04733014 Perceptions of Ophthalmologists Regarding Contemporary Presbyopia Management. Status UNKNOWN Phase N/A
NCT04699266 Clinical Investigation of the Multifocal IOL POD F GF in Cataracteous Eyes Status COMPLETED Phase NA
NCT04675151 Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia Status COMPLETED Phase PHASE2
NCT04657172 Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults Status COMPLETED Phase PHASE3
NCT04654013 PROductivity Study of Presbyopia Elimination in Rural-dwellers III Status ACTIVE_NOT_RECRUITING Phase NA
NCT04652037 Visual Results of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens Status COMPLETED Phase NA
NCT04629820 PROductivity Study of Presbyopia Elimination in Rural-dwellers II Status RECRUITING Phase NA
NCT04618380 Premium Monovision Versus Other Types of Monovision and Bilateral Trifocal Implantation. Status COMPLETED Phase N/A
NCT04618224 Development and Validation of an Internet-based Near and Intermediate-vision Reading Test Status COMPLETED Phase N/A
NCT04599972 An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2) Status COMPLETED Phase PHASE3
NCT04599933 An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1) Status COMPLETED Phase PHASE3